-
1
-
-
0001837254
-
Extensive arterial and venous thrombosis complicating chronic ulcerative colitis
-
Bargen JA, Barker NW,. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med. 1936; 58: 17-31.
-
(1936)
Arch Intern Med.
, vol.58
, pp. 17-31
-
-
Bargen, J.A.1
Barker, N.W.2
-
2
-
-
0033519051
-
Venous thrombosis: A multicausal disease
-
Rosendaal FR,. Venous thrombosis: a multicausal disease. Lancet. 1999; 353: 1167-1173.
-
(1999)
Lancet.
, vol.353
, pp. 1167-1173
-
-
Rosendaal, F.R.1
-
3
-
-
0029964844
-
Interleukin-6 stimulates coagulation, not fibrinolysis, in humans
-
Stouthard JM, Levi M, Hack CE, et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost. 1996; 76: 738-742.
-
(1996)
Thromb Haemost.
, vol.76
, pp. 738-742
-
-
Stouthard, J.M.1
Levi, M.2
Hack, C.E.3
-
4
-
-
0029974758
-
Hemostatic abnormalities in inflammatory bowel disease
-
Chiarantini E, Valanzano R, Liotta AA, et al. Hemostatic abnormalities in inflammatory bowel disease. Thromb Res. 1996; 82: 137-146.
-
(1996)
Thromb Res.
, vol.82
, pp. 137-146
-
-
Chiarantini, E.1
Valanzano, R.2
Liotta, A.A.3
-
5
-
-
0028846736
-
Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease
-
Souto JC, Martinez E, Roca M, et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci. 1995; 40: 1883-1889.
-
(1995)
Dig Dis Sci.
, vol.40
, pp. 1883-1889
-
-
Souto, J.C.1
Martinez, E.2
Roca, M.3
-
6
-
-
0029889911
-
Determination of prothrombin activation fragments in young patients with inflammatory bowel disease
-
Smith CJ, Haire WD, Kaufman SS, et al. Determination of prothrombin activation fragments in young patients with inflammatory bowel disease. Am J Gastroenterol. 1996; 91: 1221-1225.
-
(1996)
Am J Gastroenterol.
, vol.91
, pp. 1221-1225
-
-
Smith, C.J.1
Haire, W.D.2
Kaufman, S.S.3
-
7
-
-
0030864544
-
No evidence of activated blood coagulation in Crohn's disease
-
Novacek G, Kapiotis S, Moser G, et al. No evidence of activated blood coagulation in Crohn's disease. Eur J Gastroenterol Hepatol. 1997; 9: 963-967.
-
(1997)
Eur J Gastroenterol Hepatol.
, vol.9
, pp. 963-967
-
-
Novacek, G.1
Kapiotis, S.2
Moser, G.3
-
8
-
-
0026598071
-
Circulating von Willebrand factor in inflammatory bowel disease
-
Stevens TR, James JP, Simmonds NJ, et al. Circulating von Willebrand factor in inflammatory bowel disease. Gut. 1992; 33: 502-506.
-
(1992)
Gut.
, vol.33
, pp. 502-506
-
-
Stevens, T.R.1
James, J.P.2
Simmonds, N.J.3
-
9
-
-
0024550636
-
Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces
-
de Jong E, Porte RJ, Knot EA, et al. Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces. Gut. 1989; 30: 188-194.
-
(1989)
Gut.
, vol.30
, pp. 188-194
-
-
De Jong, E.1
Porte, R.J.2
Knot, E.A.3
-
10
-
-
0031057343
-
The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia
-
Levi M, van der Poll T, ten Cate H, et al. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest. 1997; 27: 3-9.
-
(1997)
Eur J Clin Invest.
, vol.27
, pp. 3-9
-
-
Levi, M.1
Van Der Poll, T.2
Ten Cate, H.3
-
11
-
-
0037469261
-
C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: Implications for the metabolic syndrome and atherothrombosis
-
Devaraj S, Xu DY, Jialal I,. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. 2003; 107: 398-404.
-
(2003)
Circulation.
, vol.107
, pp. 398-404
-
-
Devaraj, S.1
Xu, D.Y.2
Jialal, I.3
-
12
-
-
3543127813
-
Formation of platelet-leukocyte aggregates in inflammatory bowel disease
-
Irving PM, Macey MG, Shah U, et al. Formation of platelet-leukocyte aggregates in inflammatory bowel disease. Inflamm Bowel Dis. 2004; 10: 361-372.
-
(2004)
Inflamm Bowel Dis.
, vol.10
, pp. 361-372
-
-
Irving, P.M.1
MacEy, M.G.2
Shah, U.3
-
13
-
-
17444414959
-
Circulating cell-derived microparticles in Crohn's disease
-
Chamouard P, Desprez D, Hugel B, et al. Circulating cell-derived microparticles in Crohn's disease. Dig Dis Sci. 2005; 50: 574-580.
-
(2005)
Dig Dis Sci.
, vol.50
, pp. 574-580
-
-
Chamouard, P.1
Desprez, D.2
Hugel, B.3
-
14
-
-
0022656226
-
Vascular complications of inflammatory bowel disease
-
Talbot RW, Heppell J, Dozois RR, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc. 1986; 61: 140-145.
-
(1986)
Mayo Clin Proc.
, vol.61
, pp. 140-145
-
-
Talbot, R.W.1
Heppell, J.2
Dozois, R.R.3
-
15
-
-
0027401535
-
Thromboembolism in inflammatory bowel disease: Role of platelets
-
Webberley MJ, Hart MT, Melikian V,. Thromboembolism in inflammatory bowel disease: role of platelets. Gut. 1993; 34: 247-251.
-
(1993)
Gut.
, vol.34
, pp. 247-251
-
-
Webberley, M.J.1
Hart, M.T.2
Melikian, V.3
-
16
-
-
0014277999
-
Life histories of patients with chronic ulcerative colitis: A review of 2,000 cases
-
Sloan WP Jr, Bargen JA, Gage RB,. Life histories of patients with chronic ulcerative colitis: a review of 2,000 cases. Gastroenterology. 1968; 54: Suppl: 819-822.
-
(1968)
Gastroenterology.
, vol.54
, Issue.SUPPL.
, pp. 819-822
-
-
Sloan Jr., W.P.1
Bargen, J.A.2
Gage, R.B.3
-
17
-
-
0035085024
-
The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: A population-based cohort study
-
Bernstein CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001; 85: 430-434.
-
(2001)
Thromb Haemost.
, vol.85
, pp. 430-434
-
-
Bernstein, C.N.1
Blanchard, J.F.2
Houston, D.S.3
-
18
-
-
14644443651
-
Risk factors for thromboembolic complications in inflammatory bowel disease: The role of hyperhomocysteinaemia
-
Oldenburg B, Van Tuyl BA, van der Griend R, et al. Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia. Dig Dis Sci. 2005; 50: 235-240.
-
(2005)
Dig Dis Sci.
, vol.50
, pp. 235-240
-
-
Oldenburg, B.1
Van Tuyl, B.A.2
Van Der Griend, R.3
-
19
-
-
76749157063
-
Venous thromboembolism during active disease and remission in inflammatory bowel disease: A cohort study
-
Grainge MJ, West J, Card TR,. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010; 375: 657-663.
-
(2010)
Lancet.
, vol.375
, pp. 657-663
-
-
Grainge, M.J.1
West, J.2
Card, T.R.3
-
20
-
-
37449016439
-
The incidence of arterial thromboembolic diseases in inflammatory bowel disease: A population-based study
-
Bernstein CN, Wajda A, Blanchard JF,. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol. 2008; 6: 41-45.
-
(2008)
Clin Gastroenterol Hepatol.
, vol.6
, pp. 41-45
-
-
Bernstein, C.N.1
Wajda, A.2
Blanchard, J.F.3
-
21
-
-
12144288479
-
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?
-
Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut. 2004; 53: 542-548.
-
(2004)
Gut.
, vol.53
, pp. 542-548
-
-
Miehsler, W.1
Reinisch, W.2
Valic, E.3
-
23
-
-
0026579089
-
Arterial thromboembolic complications of inflammatory bowel disease. Report of three cases
-
Novotny DA, Rubin RJ, Slezak FA, et al. Arterial thromboembolic complications of inflammatory bowel disease. Report of three cases. Dis Colon Rectum. 1992; 35: 193-196.
-
(1992)
Dis Colon Rectum.
, vol.35
, pp. 193-196
-
-
Novotny, D.A.1
Rubin, R.J.2
Slezak, F.A.3
-
24
-
-
0025853696
-
Cerebrovascular complications of inflammatory bowel disease
-
Johns DR,. Cerebrovascular complications of inflammatory bowel disease. Am J Gastroenterol. 1991; 86: 367-370.
-
(1991)
Am J Gastroenterol.
, vol.86
, pp. 367-370
-
-
Johns, D.R.1
-
25
-
-
0024842920
-
Budd-Chiari syndrome and Crohn's disease. An unreported association
-
Maccini DM, Berg JC, Bell GA,. Budd-Chiari syndrome and Crohn's disease. An unreported association. Dig Dis Sci. 1989; 34: 1933-1936.
-
(1989)
Dig Dis Sci.
, vol.34
, pp. 1933-1936
-
-
MacCini, D.M.1
Berg, J.C.2
Bell, G.A.3
-
26
-
-
0018292292
-
Cerebral and retinal vascular complications of inflammatory bowel disease
-
Schneiderman JH, Sharpe JA, Sutton DM,. Cerebral and retinal vascular complications of inflammatory bowel disease. Ann Neurol. 1979; 5: 331-337.
-
(1979)
Ann Neurol.
, vol.5
, pp. 331-337
-
-
Schneiderman, J.H.1
Sharpe, J.A.2
Sutton, D.M.3
-
27
-
-
0028048123
-
Retinal vascular disease in ulcerative colitis
-
Keyser BJ, Hass AN,. Retinal vascular disease in ulcerative colitis. Am J Ophthalmol. 1994; 118: 395-396.
-
(1994)
Am J Ophthalmol.
, vol.118
, pp. 395-396
-
-
Keyser, B.J.1
Hass, A.N.2
-
29
-
-
26244444347
-
Cerebral sinus thrombosis in patients with inflammatory bowel disease: A case report
-
Umit H, Asil T, Celik Y, et al. Cerebral sinus thrombosis in patients with inflammatory bowel disease: a case report. World J Gastroenterol. 2005; 11: 5404-5407.
-
(2005)
World J Gastroenterol.
, vol.11
, pp. 5404-5407
-
-
Umit, H.1
Asil, T.2
Celik, Y.3
-
30
-
-
1642533660
-
Cerebral venous thrombosis in acute inflammatory bowel disease
-
206.
-
Singh G, Sarkar S, Manoj K, et al. Cerebral venous thrombosis in acute inflammatory bowel disease. Gut. 2004; 53: 161, 206.
-
(2004)
Gut.
, vol.53
, pp. 161
-
-
Singh, G.1
Sarkar, S.2
Manoj, K.3
-
31
-
-
27644460489
-
Increased carotid intima-media thickness in patients with inflammatory bowel disease
-
Papa A, Santoliquido A, Danese S, et al. Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005; 22: 839-846.
-
(2005)
Aliment Pharmacol Ther.
, vol.22
, pp. 839-846
-
-
Papa, A.1
Santoliquido, A.2
Danese, S.3
-
32
-
-
70349256406
-
Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: A case report and review of the literature
-
Fabi SG, Hill C, Witherspoon JN, et al. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature. J Drugs Dermatol. 2009; 8: 765-769.
-
(2009)
J Drugs Dermatol.
, vol.8
, pp. 765-769
-
-
Fabi, S.G.1
Hill, C.2
Witherspoon, J.N.3
-
34
-
-
33646883735
-
Efficacy of prophylactic warfarin for prevention of thalidomide-related deep venous thrombosis
-
Ikhlaque N, Seshadri V, Kathula S, et al. Efficacy of prophylactic warfarin for prevention of thalidomide-related deep venous thrombosis. Am J Hematol. 2006; 81: 420-422.
-
(2006)
Am J Hematol.
, vol.81
, pp. 420-422
-
-
Ikhlaque, N.1
Seshadri, V.2
Kathula, S.3
-
35
-
-
0023644095
-
Fibrinogen and risk of cardiovascular disease
-
the Framingham Study
-
Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA. 1987; 258: 1183-1186.
-
(1987)
JAMA
, vol.258
, pp. 1183-1186
-
-
Kannel, W.B.1
Wolf, P.A.2
Castelli, W.P.3
-
36
-
-
0021210911
-
Fibrinogen as a risk factor for stroke and myocardial infarction
-
Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984; 311: 501-505.
-
(1984)
N Engl J Med.
, vol.311
, pp. 501-505
-
-
Wilhelmsen, L.1
Svardsudd, K.2
Korsan-Bengtsen, K.3
-
37
-
-
0022485106
-
Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
-
Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986; 2: 533-537.
-
(1986)
Lancet.
, vol.2
, pp. 533-537
-
-
Meade, T.W.1
Mellows, S.2
Brozovic, M.3
-
38
-
-
0022317310
-
Plasma fibrinogen-a major coronary risk factor
-
Stone MC, Thorp JM,. Plasma fibrinogen-a major coronary risk factor. J R Coll Gen Pract. 1985; 35: 565-569.
-
(1985)
J R Coll Gen Pract.
, vol.35
, pp. 565-569
-
-
Stone, M.C.1
Thorp, J.M.2
-
39
-
-
0022908186
-
Blood rheology in arterial disease
-
Lowe GD,. Blood rheology in arterial disease. Clin Sci (Lond). 1986; 71: 137-146.
-
(1986)
Clin Sci (Lond).
, vol.71
, pp. 137-146
-
-
Lowe, G.D.1
-
40
-
-
0017070372
-
Macrophage plasminogen activator: Modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides
-
Vassalli JD, Hamilton J, Reich E,. Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell. 1976; 8: 271-281.
-
(1976)
Cell.
, vol.8
, pp. 271-281
-
-
Vassalli, J.D.1
Hamilton, J.2
Reich, E.3
-
41
-
-
0017651179
-
Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors
-
Granelli-Piperno A, Vassalli JD, Reich E,. Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors. J Exp Med. 1977; 146: 1693-1706.
-
(1977)
J Exp Med.
, vol.146
, pp. 1693-1706
-
-
Granelli-Piperno, A.1
Vassalli, J.D.2
Reich, E.3
-
42
-
-
0021134150
-
The effects of betamimetics and glucocorticoids on fetal vascular prostacyclin and platelet thromboxane synthesis in humans
-
Makila UM,. The effects of betamimetics and glucocorticoids on fetal vascular prostacyclin and platelet thromboxane synthesis in humans. Prostaglandins Leukot Med. 1984; 16: 11-17.
-
(1984)
Prostaglandins Leukot Med.
, vol.16
, pp. 11-17
-
-
Makila, U.M.1
-
43
-
-
0017890459
-
Lack of effect of prednisone administration on bleeding time and platelet function of normal subjects
-
Thong KL, Mant MJ, Grace MG,. Lack of effect of prednisone administration on bleeding time and platelet function of normal subjects. Br J Haematol. 1978; 38: 373-380.
-
(1978)
Br J Haematol.
, vol.38
, pp. 373-380
-
-
Thong, K.L.1
Mant, M.J.2
Grace, M.G.3
-
44
-
-
0022572140
-
Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells
-
Lewis GD, Campbell WB, Johnson AR,. Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells. Endocrinology. 1986; 119: 62-69.
-
(1986)
Endocrinology.
, vol.119
, pp. 62-69
-
-
Lewis, G.D.1
Campbell, W.B.2
Johnson, A.R.3
-
45
-
-
0028606887
-
Corticosteroids: Do they damage the cardiovascular system?
-
Maxwell SR, Moots RJ, Kendall MJ,. Corticosteroids: do they damage the cardiovascular system? Postgrad Med J. 1994; 70: 863-870.
-
(1994)
Postgrad Med J.
, vol.70
, pp. 863-870
-
-
Maxwell, S.R.1
Moots, R.J.2
Kendall, M.J.3
-
46
-
-
33846407948
-
Risk factors and clinical impact of postoperative symptomatic venous thromboembolism
-
discussion 341-332.
-
Gangireddy C, Rectenwald JR, Upchurch GR, et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg. 2007; 45: 335-341; discussion 341-332.
-
(2007)
J Vasc Surg.
, vol.45
, pp. 335-341
-
-
Gangireddy, C.1
Rectenwald, J.R.2
Upchurch, G.R.3
-
47
-
-
33846036404
-
Inflammation and coagulation in inflammatory bowel disease: The clot thickens
-
Danese S, Papa A, Saibeni S, et al. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol. 2007; 102: 174-186.
-
(2007)
Am J Gastroenterol.
, vol.102
, pp. 174-186
-
-
Danese, S.1
Papa, A.2
Saibeni, S.3
-
48
-
-
0033801479
-
Inhibition of platelet activation by 5-aminosalicylic acid in inflammatory bowel disease
-
Carty E, MacEy M, Rampton DS,. Inhibition of platelet activation by 5-aminosalicylic acid in inflammatory bowel disease. Aliment Pharmacol Ther. 2000; 14: 1169-1179.
-
(2000)
Aliment Pharmacol Ther.
, vol.14
, pp. 1169-1179
-
-
Carty, E.1
MacEy, M.2
Rampton, D.S.3
-
49
-
-
0033798272
-
Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease
-
Fagerstam JP, Whiss PA, Strom M, et al. Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease. Inflamm Res. 2000; 49: 466-472.
-
(2000)
Inflamm Res.
, vol.49
, pp. 466-472
-
-
Fagerstam, J.P.1
Whiss, P.A.2
Strom, M.3
-
50
-
-
0023635639
-
Lack of effect of 5-aminosalicylic acid on platelet aggregation and fibrinolytic activity in vivo and in vitro
-
Winther K, Bondesen S, Hansen SH, et al. Lack of effect of 5-aminosalicylic acid on platelet aggregation and fibrinolytic activity in vivo and in vitro. Eur J Clin Pharmacol. 1987; 33: 419-422.
-
(1987)
Eur J Clin Pharmacol.
, vol.33
, pp. 419-422
-
-
Winther, K.1
Bondesen, S.2
Hansen, S.H.3
-
51
-
-
33947314966
-
CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon
-
Vowinkel T, Anthoni C, Wood KC, et al. CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon. Gastroenterology. 2007; 132: 955-965.
-
(2007)
Gastroenterology.
, vol.132
, pp. 955-965
-
-
Vowinkel, T.1
Anthoni, C.2
Wood, K.C.3
-
53
-
-
34247877467
-
Vascular and cellular stress in inflammatory bowel disease: Revisiting the role of homocysteine
-
Peyrin-Biroulet L, Rodriguez-Gueant RM, Chamaillard M, et al. Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine. Am J Gastroenterol. 2007; 102: 1108-1115.
-
(2007)
Am J Gastroenterol.
, vol.102
, pp. 1108-1115
-
-
Peyrin-Biroulet, L.1
Rodriguez-Gueant, R.M.2
Chamaillard, M.3
-
54
-
-
0033635087
-
Oral tacrolimus treatment of severe colitis in children
-
Bousvaros A, Kirschner BS, Werlin SL, et al. Oral tacrolimus treatment of severe colitis in children. J Pediatr. 2000; 137: 794-799.
-
(2000)
J Pediatr.
, vol.137
, pp. 794-799
-
-
Bousvaros, A.1
Kirschner, B.S.2
Werlin, S.L.3
-
55
-
-
0027965108
-
Long-term efficacy and safety of cyclosporine in renal-transplant recipients
-
Burke JF Jr, Pirsch JD, Ramos EL, et al. Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med. 1994; 331: 358-363.
-
(1994)
N Engl J Med.
, vol.331
, pp. 358-363
-
-
Burke Jr., J.F.1
Pirsch, J.D.2
Ramos, E.L.3
-
56
-
-
0026048757
-
Cyclosporin A augments human platelet sensitivity to aggregating agents by increasing fibrinogen receptor availability
-
Fishman SJ, Wylonis LJ, Glickman JD, et al. Cyclosporin A augments human platelet sensitivity to aggregating agents by increasing fibrinogen receptor availability. J Surg Res. 1991; 51: 93-98.
-
(1991)
J Surg Res.
, vol.51
, pp. 93-98
-
-
Fishman, S.J.1
Wylonis, L.J.2
Glickman, J.D.3
-
57
-
-
0030174289
-
Cyclosporine-induced detachment of vascular endothelial cells initiates the intrinsic coagulation system in plasma and whole blood
-
Bombeli T, Muller M, Straub PW, et al. Cyclosporine-induced detachment of vascular endothelial cells initiates the intrinsic coagulation system in plasma and whole blood. J Lab Clin Med. 1996; 127: 621-634.
-
(1996)
J Lab Clin Med.
, vol.127
, pp. 621-634
-
-
Bombeli, T.1
Muller, M.2
Straub, P.W.3
-
58
-
-
0021881063
-
Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients
-
Vanrenterghem Y, Roels L, Lerut T, et al. Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet. 1985; 1: 999-1002.
-
(1985)
Lancet.
, vol.1
, pp. 999-1002
-
-
Vanrenterghem, Y.1
Roels, L.2
Lerut, T.3
-
60
-
-
3042658278
-
Cerebral sinus thrombosis associated with severe active ulcerative colitis
-
Murata S, Ishikawa N, Oshikawa S, et al. Cerebral sinus thrombosis associated with severe active ulcerative colitis. Intern Med. 2004; 43: 400-403.
-
(2004)
Intern Med.
, vol.43
, pp. 400-403
-
-
Murata, S.1
Ishikawa, N.2
Oshikawa, S.3
-
61
-
-
0023038704
-
Increased incidence of renal allograft thrombosis under cyclosporine immunosuppression
-
Rigotti P, Flechner SM, Van Buren CT, et al. Increased incidence of renal allograft thrombosis under cyclosporine immunosuppression. Int Surg. 1986; 71: 38-41.
-
(1986)
Int Surg.
, vol.71
, pp. 38-41
-
-
Rigotti, P.1
Flechner, S.M.2
Van Buren, C.T.3
-
62
-
-
33749125866
-
Subclinical inflammation and prothrombotic state in heart transplant recipients: Impact of cyclosporin microemulsion vs. tacrolimus
-
White M, Ross H, Haddad H, et al. Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus. Transplantation. 2006; 82: 763-770.
-
(2006)
Transplantation.
, vol.82
, pp. 763-770
-
-
White, M.1
Ross, H.2
Haddad, H.3
-
63
-
-
0023553252
-
Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine- antilymphocyte globulin
-
Gruber SA, Pescovitz MD, Simmons RL, et al. Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin. Transplantation. 1987; 44: 775-778.
-
(1987)
Transplantation.
, vol.44
, pp. 775-778
-
-
Gruber, S.A.1
Pescovitz, M.D.2
Simmons, R.L.3
-
64
-
-
0037006627
-
Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: A randomised multicentre study
-
DOI 10.1016/S0140-6736(02)07875-3
-
Margreiter R,. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet. 2002; 359: 741-746. (Pubitemid 34215073)
-
(2002)
Lancet
, vol.359
, Issue.9308
, pp. 741-746
-
-
Margreiter, R.1
-
65
-
-
38549102077
-
TNF-mediated inflammatory disease
-
Bradley JR,. TNF-mediated inflammatory disease. J Pathol. 2008; 214: 149-160.
-
(2008)
J Pathol.
, vol.214
, pp. 149-160
-
-
Bradley, J.R.1
-
66
-
-
32044474228
-
TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: A novel anti-inflammatory mechanism of infliximab in Crohn's disease
-
Danese S, Sans M, Scaldaferri F, et al. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. J Immunol. 2006; 176: 2617-2624.
-
(2006)
J Immunol.
, vol.176
, pp. 2617-2624
-
-
Danese, S.1
Sans, M.2
Scaldaferri, F.3
-
67
-
-
33751334334
-
Safety of infliximab and other biologic agents in the inflammatory bowel diseases
-
Reddy JG, Loftus EV Jr,. Safety of infliximab and other biologic agents in the inflammatory bowel diseases. Gastroenterol Clin North Am. 2006; 35: 837-855.
-
(2006)
Gastroenterol Clin North Am.
, vol.35
, pp. 837-855
-
-
Reddy, J.G.1
Loftus Jr., E.V.2
-
68
-
-
4444246999
-
Extensive forearm deep venous thrombosis following a severe infliximab infusion reaction
-
Ryan BM, Romberg M, Wolters F, et al. Extensive forearm deep venous thrombosis following a severe infliximab infusion reaction. Eur J Gastroenterol Hepatol. 2004; 16: 941-942.
-
(2004)
Eur J Gastroenterol Hepatol.
, vol.16
, pp. 941-942
-
-
Ryan, B.M.1
Romberg, M.2
Wolters, F.3
-
69
-
-
0033586755
-
Activated protein C resistance and factor v Leiden mutation are independent risk factors for venous thromboembolism
-
Rodeghiero F, Tosetto A,. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Ann Intern Med. 1999; 130: 643-650.
-
(1999)
Ann Intern Med.
, vol.130
, pp. 643-650
-
-
Rodeghiero, F.1
Tosetto, A.2
-
70
-
-
0028931717
-
High risk of thrombosis in patients homozygous for factor v Leiden (activated protein C resistance)
-
Rosendaal FR, Koster T, Vandenbroucke JP, et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995; 85: 1504-1508.
-
(1995)
Blood.
, vol.85
, pp. 1504-1508
-
-
Rosendaal, F.R.1
Koster, T.2
Vandenbroucke, J.P.3
-
71
-
-
0031761730
-
Factor v Leiden mutation is not increased in patients with inflammatory bowel disease
-
Zauber NP, Sabbath-Solitare M, Rajoria G, et al. Factor V Leiden mutation is not increased in patients with inflammatory bowel disease. J Clin Gastroenterol. 1998; 27: 215-216.
-
(1998)
J Clin Gastroenterol.
, vol.27
, pp. 215-216
-
-
Zauber, N.P.1
Sabbath-Solitare, M.2
Rajoria, G.3
-
72
-
-
0032979156
-
Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease
-
Novacek G, Miehsler W, Kapiotis S, et al. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease. Am J Gastroenterol. 1999; 94: 685-690.
-
(1999)
Am J Gastroenterol.
, vol.94
, pp. 685-690
-
-
Novacek, G.1
Miehsler, W.2
Kapiotis, S.3
-
73
-
-
34548672796
-
Factor v Leiden and the etiology of inflammatory bowel disease
-
Spek CA, ten Kate FJ, te Velde AA,. Factor V Leiden and the etiology of inflammatory bowel disease. Thromb Haemost. 2007; 98: 670-673.
-
(2007)
Thromb Haemost.
, vol.98
, pp. 670-673
-
-
Spek, C.A.1
Ten Kate, F.J.2
Te Velde, A.A.3
-
74
-
-
0029850530
-
A common genetic variation in the 3â-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
-
Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3â-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996; 88: 3698-3703.
-
(1996)
Blood.
, vol.88
, pp. 3698-3703
-
-
Poort, S.R.1
Rosendaal, F.R.2
Reitsma, P.H.3
-
75
-
-
0031847816
-
Increased risk for venous thrombosis in carriers of the prothrombin G->A20210 gene variant
-
Margaglione M, Brancaccio V, Giuliani N, et al. Increased risk for venous thrombosis in carriers of the prothrombin G->A20210 gene variant. Ann Intern Med. 1998; 129: 89-93.
-
(1998)
Ann Intern Med.
, vol.129
, pp. 89-93
-
-
Margaglione, M.1
Brancaccio, V.2
Giuliani, N.3
-
76
-
-
0033869354
-
Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis
-
Vecchi M, Sacchi E, Saibeni S, et al. Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis. Dig Dis Sci. 2000; 45: 1465-1469.
-
(2000)
Dig Dis Sci.
, vol.45
, pp. 1465-1469
-
-
Vecchi, M.1
Sacchi, E.2
Saibeni, S.3
-
77
-
-
0036145049
-
Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease
-
Bjerregaard LT, Nederby NJ, Fredholm L, et al. Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002; 37: 62-67.
-
(2002)
Scand J Gastroenterol.
, vol.37
, pp. 62-67
-
-
Bjerregaard, L.T.1
Nederby, N.J.2
Fredholm, L.3
-
78
-
-
0033938933
-
Inflammatory bowel disease promotes venous thrombosis earlier in life
-
Grip O, Svensson PJ, Lindgren S,. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol. 2000; 35: 619-623.
-
(2000)
Scand J Gastroenterol.
, vol.35
, pp. 619-623
-
-
Grip, O.1
Svensson, P.J.2
Lindgren, S.3
-
79
-
-
0343807499
-
Prothrombotic inherited abnormalities other than factor v Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease
-
Guedon C, Le Cam-Duchez V, Lalaude O, et al. Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease. Am J Gastroenterol. 2001; 96: 1448-1454.
-
(2001)
Am J Gastroenterol.
, vol.96
, pp. 1448-1454
-
-
Guedon, C.1
Le Cam-Duchez, V.2
Lalaude, O.3
-
80
-
-
0030895756
-
Thrombosis in inflammatory bowel disease: Clinical setting, procoagulant profile and factor v Leiden
-
Jackson LM, O'Gorman PJ, O'Connell J, et al. Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden. QJM. 1997; 90: 183-188.
-
(1997)
QJM
, vol.90
, pp. 183-188
-
-
Jackson, L.M.1
O'Gorman, P.J.2
O'Connell, J.3
-
81
-
-
0026439018
-
Free protein S deficiency in patients with chronic inflammatory bowel disease
-
Aadland E, Odegaard OR, Roseth A, et al. Free protein S deficiency in patients with chronic inflammatory bowel disease. Scand J Gastroenterol. 1992; 27: 957-960.
-
(1992)
Scand J Gastroenterol.
, vol.27
, pp. 957-960
-
-
Aadland, E.1
Odegaard, O.R.2
Roseth, A.3
-
82
-
-
33845252483
-
A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: Data from Turkey
-
Yilmaz S, Bayan K, Tuzun Y, et al. A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey. J Thromb Thrombolysis. 2006; 22: 205-212.
-
(2006)
J Thromb Thrombolysis.
, vol.22
, pp. 205-212
-
-
Yilmaz, S.1
Bayan, K.2
Tuzun, Y.3
-
83
-
-
0029143073
-
Antiphospholipid antibodies in inflammatory bowel disease
-
Souto JC, Borrell M, Fontcuberta J, et al. Antiphospholipid antibodies in inflammatory bowel disease. Dig Dis Sci. 1995; 40: 1524-1525.
-
(1995)
Dig Dis Sci.
, vol.40
, pp. 1524-1525
-
-
Souto, J.C.1
Borrell, M.2
Fontcuberta, J.3
-
85
-
-
0031771785
-
Anti-cardiolipin and anti-beta2-glycoprotein i antibodies in patients with inflammatory bowel disease
-
Koutroubakis IE, Petinaki E, Anagnostopoulou E, et al. Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease. Dig Dis Sci. 1998; 43: 2507-2512.
-
(1998)
Dig Dis Sci.
, vol.43
, pp. 2507-2512
-
-
Koutroubakis, I.E.1
Petinaki, E.2
Anagnostopoulou, E.3
-
86
-
-
0031593869
-
High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: A pathogenic link with thromboembolic complications?
-
Cattaneo M, Vecchi M, Zighetti ML, et al. High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? Thromb Haemost. 1998; 80: 542-545.
-
(1998)
Thromb Haemost.
, vol.80
, pp. 542-545
-
-
Cattaneo, M.1
Vecchi, M.2
Zighetti, M.L.3
-
87
-
-
69949103268
-
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: Results of the MEGA case-control study
-
van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, et al. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ. 2009; 339: b2921.-
-
(2009)
BMJ
, vol.339
-
-
Van Hylckama Vlieg, A.1
Helmerhorst, F.M.2
Vandenbroucke, J.P.3
-
88
-
-
12444304442
-
Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study
-
Mitchell L, Andrew M, Hanna K, et al. Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study. Thromb Haemost. 2003; 90: 235-244.
-
(2003)
Thromb Haemost.
, vol.90
, pp. 235-244
-
-
Mitchell, L.1
Andrew, M.2
Hanna, K.3
-
89
-
-
4243382688
-
The sensitivity and specificity of lineograms and ultrasound compared to venography for the diagnosis of central venous line related thrombosis in symptomatic children: The LUV study [abstract
-
Chait P, Dinyari M, Massicotte MP,. The sensitivity and specificity of lineograms and ultrasound compared to venography for the diagnosis of central venous line related thrombosis in symptomatic children: the LUV study [abstract]. Thromb Haemost. 2001;(suppl): P697.
-
(2001)
Thromb Haemost.
, Issue.SUPPL.
-
-
Chait, P.1
Dinyari, M.2
Massicotte, M.P.3
-
90
-
-
0036152065
-
Magnetic resonance venography in assessing venous patency after multiple venous catheters
-
Shankar KR, Abernethy LJ, Das KS, et al. Magnetic resonance venography in assessing venous patency after multiple venous catheters. J Pediatr Surg. 2002; 37: 175-179.
-
(2002)
J Pediatr Surg.
, vol.37
, pp. 175-179
-
-
Shankar, K.R.1
Abernethy, L.J.2
Das, K.S.3
-
91
-
-
0030963804
-
Echocardiography Doppler in pulmonary embolism: Right ventricular dysfunction as a predictor of mortality rate
-
Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, et al. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J. 1997; 134: 479-487.
-
(1997)
Am Heart J.
, vol.134
, pp. 479-487
-
-
Ribeiro, A.1
Lindmarker, P.2
Juhlin-Dannfelt, A.3
-
92
-
-
32844466981
-
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: Randomised placebo controlled trial
-
Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ. 2006; 332: 325-329.
-
(2006)
BMJ
, vol.332
, pp. 325-329
-
-
Cohen, A.T.1
Davidson, B.L.2
Gallus, A.S.3
-
93
-
-
4143085802
-
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
-
Leizorovicz A, Cohen AT, Turpie AG, et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004; 110: 874-879.
-
(2004)
Circulation.
, vol.110
, pp. 874-879
-
-
Leizorovicz, A.1
Cohen, A.T.2
Turpie, A.G.3
-
94
-
-
0033539025
-
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group
-
Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 1999; 341: 793-800.
-
(1999)
N Engl J Med.
, vol.341
, pp. 793-800
-
-
Samama, M.M.1
Cohen, A.T.2
Darmon, J.Y.3
-
95
-
-
46049090201
-
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 8th ed
-
Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 8th ed. Chest. 2008; 133: 381S-453S.
-
(2008)
Chest.
, vol.133
-
-
Geerts, W.H.1
Bergqvist, D.2
Pineo, G.F.3
-
97
-
-
0028949781
-
Inherited disorders of coagulation appear to protect against inflammatory bowel disease
-
Thompson NP, Wakefield AJ, Pounder RE,. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology. 1995; 108: 1011-1015.
-
(1995)
Gastroenterology.
, vol.108
, pp. 1011-1015
-
-
Thompson, N.P.1
Wakefield, A.J.2
Pounder, R.E.3
-
98
-
-
0028814834
-
Paradoxical response to heparin in 10 patients with ulcerative colitis
-
Gaffney PR, Doyle CT, Gaffney A, et al. Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol. 1995; 90: 220-223.
-
(1995)
Am J Gastroenterol.
, vol.90
, pp. 220-223
-
-
Gaffney, P.R.1
Doyle, C.T.2
Gaffney, A.3
-
99
-
-
0032975985
-
Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease
-
Folwaczny C, Wiebecke B, Loeschke K,. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol. 1999; 94: 1551-1555.
-
(1999)
Am J Gastroenterol.
, vol.94
, pp. 1551-1555
-
-
Folwaczny, C.1
Wiebecke, B.2
Loeschke, K.3
-
100
-
-
0030816854
-
Treatment of corticosteroid-resistant ulcerative colitis with heparin-a report of 16 cases
-
Evans RC, Wong VS, Morris AI, et al. Treatment of corticosteroid- resistant ulcerative colitis with heparin-a report of 16 cases. Aliment Pharmacol Ther. 1997; 11: 1037-1040.
-
(1997)
Aliment Pharmacol Ther.
, vol.11
, pp. 1037-1040
-
-
Evans, R.C.1
Wong, V.S.2
Morris, A.I.3
-
101
-
-
0033852957
-
Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease
-
Ang YS, Mahmud N, White B, et al. Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease. Aliment Pharmacol Ther. 2000; 14: 1015-1022.
-
(2000)
Aliment Pharmacol Ther.
, vol.14
, pp. 1015-1022
-
-
Ang, Y.S.1
Mahmud, N.2
White, B.3
-
102
-
-
0032847644
-
Low molecular weight heparin as adjuvant therapy in active ulcerative colitis
-
Torkvist L, Thorlacius H, Sjoqvist U, et al. Low molecular weight heparin as adjuvant therapy in active ulcerative colitis. Aliment Pharmacol Ther. 1999; 13: 1323-1328.
-
(1999)
Aliment Pharmacol Ther.
, vol.13
, pp. 1323-1328
-
-
Torkvist, L.1
Thorlacius, H.2
Sjoqvist, U.3
-
103
-
-
0034794370
-
Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: An open trial
-
Dotan I, Hallak A, Arber N, et al. Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial. Dig Dis Sci. 2001; 46: 2239-2244.
-
(2001)
Dig Dis Sci.
, vol.46
, pp. 2239-2244
-
-
Dotan, I.1
Hallak, A.2
Arber, N.3
-
104
-
-
0033777998
-
Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis
-
Panes J, Esteve M, Cabre E, et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology. 2000; 119: 903-908.
-
(2000)
Gastroenterology.
, vol.119
, pp. 903-908
-
-
Panes, J.1
Esteve, M.2
Cabre, E.3
-
105
-
-
11144358357
-
Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis
-
Bloom S, Kiilerich S, Lassen MR, et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther. 2004; 19: 871-878.
-
(2004)
Aliment Pharmacol Ther.
, vol.19
, pp. 871-878
-
-
Bloom, S.1
Kiilerich, S.2
Lassen, M.R.3
-
106
-
-
33646240158
-
Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: A randomized, controlled, comparative study
-
Zezos P, Papaioannou G, Nikolaidis N, et al. Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther. 2006; 23: 1443-1453.
-
(2006)
Aliment Pharmacol Ther.
, vol.23
, pp. 1443-1453
-
-
Zezos, P.1
Papaioannou, G.2
Nikolaidis, N.3
-
107
-
-
34250357545
-
Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis
-
de Bievre MA, Vrij AA, Schoon EJ, et al. Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis. 2007; 13: 753-758.
-
(2007)
Inflamm Bowel Dis.
, vol.13
, pp. 753-758
-
-
De Bievre, M.A.1
Vrij, A.A.2
Schoon, E.J.3
-
108
-
-
34547844145
-
Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis
-
Shen J, Ran ZH, Tong JL, et al. Meta-analysis: the utility and safety of heparin in the treatment of active ulcerative colitis. Aliment Pharmacol Ther. 2007; 26: 653-663.
-
(2007)
Aliment Pharmacol Ther.
, vol.26
, pp. 653-663
-
-
Shen, J.1
Ran, Z.H.2
Tong, J.L.3
-
109
-
-
0033519974
-
Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease
-
Day R, Forbes A,. Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease. Lancet. 1999; 354: 62-65.
-
(1999)
Lancet.
, vol.354
, pp. 62-65
-
-
Day, R.1
Forbes, A.2
-
110
-
-
0000477658
-
Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin
-
Cui HF, Jiang XL,. Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin. World J Gastroenterol. 1999; 5: 448-450.
-
(1999)
World J Gastroenterol.
, vol.5
, pp. 448-450
-
-
Cui, H.F.1
Jiang, X.L.2
-
111
-
-
48449091370
-
Oral, colonic-release low-molecular-weight heparin: An initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis
-
Pastorelli L, Saibeni S, Spina L, et al. Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis. Aliment Pharmacol Ther. 2008; 28: 581-588.
-
(2008)
Aliment Pharmacol Ther.
, vol.28
, pp. 581-588
-
-
Pastorelli, L.1
Saibeni, S.2
Spina, L.3
|